Pro-Lab launches Pro-AMP for physician office molecular testing

Pro-Lab Diagnostics USA has introduced Pro-AMP, an isothermal nucleic acid amplification platform for qualified physician office laboratories and other certified labs. The company says the system is meant to make infectious disease testing faster, more flexible, and easier to deploy in practice settings.

Why it matters: - Pro-AMP is aimed at moving infectious disease molecular testing closer to the point of care in physician office laboratories and specialty practices. - The platform is designed to support faster turnaround, more targeted testing, and workflows that fit clinical and billing requirements. - Pro-Lab is positioning the product for settings that need practical testing without adding complex PCR infrastructure.

What happened: - Pro-Lab Diagnostics USA announced Pro-AMP, an isothermal nucleic acid amplification platform for qualified physician office laboratories, specialty practices, and high-complexity CLIA-certified laboratories. - The platform supports infectious disease molecular testing across urogenital, respiratory, wound, and antibiotic resistance gene detection use cases. - CEO Robert Rae said the product was developed to give physician practices and lab partners a flexible molecular platform for patient-specific testing.

The details: - Pro-AMP is built around configurable isothermal workflows that can be adapted to the patient, specimen type, clinical presentation, ordering provider, medical necessity, and compliance requirements. - The platform uses configurable multi-target assay selection instead of a fixed panel structure. - Pro-Lab says the design allows laboratories to organize testing around pathogens, resistance markers, and diagnostic categories. - Unlike conventional PCR, isothermal amplification runs at a constant temperature. - That approach can reduce instrument complexity, simplify workflow design, and support faster, more cost-efficient testing. - Pro-AMP is intended to work with automated or semi-automated laboratory workflows. - The company says the platform can support sample collection, laboratory operations, reporting, inventory management, compliance, and scalable testing programs. - The product is designed for qualified laboratories using properly validated LDT workflows. - Pro-AMP is intended to support patient-specific target selection, configurable multi-target workflows, physician office lab deployment, billing and compliance alignment, rapid workflow design, simplified interpretation, scalability, cost efficiency, flexible deployment, and clinical relevance. - The company says reporting models may support same-day or next-day results depending on specimen handling, extraction, validation, staffing, and reporting processes. - Pro-Lab says the menu can be configured for respiratory disease, women’s health, urinary tract infections, wound infections, gastrointestinal pathogens, sexually transmitted infections, and resistance markers. - In women’s health, the company points to use in vaginitis, vulvovaginal candidiasis, sexually transmitted infections, and urinary tract infections. - In wound care and antimicrobial resistance, the company says faster pathogen and resistance-gene information can help guide therapy and reduce empiric treatment.

Between the lines: - Pro-Lab is betting that labs want more flexible testing menus than rigid panel-based systems. - The pitch also reflects a broader push in diagnostics toward faster, more actionable results for treatment, triage, isolation, and antimicrobial stewardship. - The regulatory notice makes clear the product is meant for qualified laboratories, not home use or over-the-counter use unless separately authorized.

What's next: - Pro-Lab intends Pro-AMP to support physician office laboratories, healthcare systems, public health programs, and laboratory testing partners. - The company also sees potential use in surveillance, antimicrobial resistance monitoring, and epidemiological research. - Availability and performance will depend on each laboratory’s validation, CLIA status, personnel qualifications, payer requirements, and state and federal rules.

The bottom line: - Pro-AMP is Pro-Lab’s attempt to package flexible infectious disease molecular testing for lab settings that need speed, compliance, and patient-specific target selection.